A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice Article

Kassa, Jiri, Karasova, Jana, Bajgar, Jiri et al. (2008). A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice . 23(6), 776-780. 10.1080/14756360701809902

Open Access

cited authors

  • Kassa, Jiri; Karasova, Jana; Bajgar, Jiri; Kuca, Kamil; Musilek, Kamil

sustainable development goals

authors

publication date

  • January 1, 2008

keywords

  • ANTIDOTAL TREATMENT
  • Biochemistry & Molecular Biology
  • Chemistry, Medicinal
  • H OXIMES
  • HI-6
  • IN-VIVO METHODS
  • K206
  • K269
  • Life Sciences & Biomedicine
  • NERVE AGENTS
  • OBIDOXIME
  • ORGANOPHOSPHORUS COMPOUNDS
  • PARAOXON-INHIBITED ACETYLCHOLINESTERASE
  • PRALIDOXIME
  • Pharmacology & Pharmacy
  • Science & Technology
  • VITRO
  • acetylcholinesterase
  • acetylthiocholine
  • inhibition
  • obidoxime
  • reactivation
  • tabun
  • trimedoxime

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 776

end page

  • 780

volume

  • 23

issue

  • 6